Treatment of children with medulloblastoma without metastatic involvement in the age group older than 3 years: international experience and results of intercenter trial
Background. During the past 20 years, some large international studies have been conducted that evaluated the effectiveness of treatment programs for children with medulloblastoma. At the same time, in the standard risk group, fairly high rates of 5-year overall survival (OS) and event-free survival...
Guardado en:
Autores principales: | Andrei S. Levashov, Svetlana R. Zagidullina, Anna M. Stroganova, Dmitrii A. Khochenkov, Marina V. Ryzhova, Sergei K. Gorelyshev, Shavkat U. Kadirov, Stepan S. Babelyan, Vasilii A. Grigorenko, Dmitrii A. Sidel’nikov, Natalia N. Subbotina, Vidmante V. Daylidite, Georgii L. Mentkevich |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
IP Habib O.N.
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a12eb34ca0b74cc593911e1f8ebacdcb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
CAR T Cell Therapy’s Potential for Pediatric Brain Tumors
por: Pauline Thomas, et al.
Publicado: (2021) -
The impact of magnetic resonance imaging spectroscopy parameters on differentiating between paediatric medulloblastoma and ependymoma
por: Nguyen Minh Duc
Publicado: (2021) -
Immunotherapy in Medulloblastoma: Current State of Research, Challenges, and Future Perspectives
por: Marije J. Voskamp, et al.
Publicado: (2021) -
An Integrated Analysis of Tumor Purity of Common Central Nervous System Tumors in Children Based on Machine Learning Methods
por: Jian Yang, et al.
Publicado: (2021) -
Identification of an Immunogenic Medulloblastoma-Specific Fusion Involving <i>EPC2</i> and <i>GULP1</i>
por: Claudia Paret, et al.
Publicado: (2021)